StockNews.com assumed coverage on shares of Oragenics (NYSEAMERICAN:OGEN – Free Report) in a research note published on Sunday morning. The firm issued a sell rating on the biotechnology company’s stock. Oragenics Stock Performance Shares of OGEN stock opened at $3.40 on Friday. The business has a fifty day moving average of $3.41 and a 200 […]